Macitentan as a repurposed MCL-1 inhibitor in triple-negative breast cancer: Insights from molecular docking, MM-GBSA, and MD simulations. - Fadlalla, Abdalla; Makki, Alaa A.; Ibraheem, Walaa; Abdelrhman, Mohammed; Alzain, Abdulrahim A.; Ashour, Ahmed; Osman, Wadah; Alqarni, Mohammed Hamed; Foudah, Ahmed I.; El-Sakhawy, Mohamed A. (Journal of King Saud University - Science, 2026)